BofA raised the firm’s price target on Cohen & Steers to $71 from $68 and keeps an Underperform rating on the shares. C&S reported better-than-expected Q3 results, including an EPS beat, and management raised the 2025 G&A growth guidance to 9%, announced $500M-$600M of pending redemptions and a $1.8B unfunded pipeline on the earnings call, the analyst tells investors. While flows appear to be improving, redemptions remain elevated and high-interest rates will continue to be a headwind, says the analyst, who maintains an Underperform rating due to challenges in real estate.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CNS:
- Sell Rating Maintained for Cohen & Steers Amid Redemption Concerns and Real Estate Challenges
- Cohen & Steers Reports Steady Q3 2025 Results
- Closing Bell Movers: CSX gains over 2% on earnings beat; OZK slips on miss
- Cohen & Steers reports Q3 EPS adjusted EPS 81c vs. 73c last quarter
- Is CNS a Buy, Before Earnings?
